Literature DB >> 25190652

Age-related differences in longitudinal structural change by spectral-domain optical coherence tomography in early experimental glaucoma.

Hongli Yang1, Lin He1, Stuart K Gardiner2, Juan Reynaud1, Galen Williams1, Christy Hardin1, Nicholas G Strouthidis3, J Crawford Downs4, Brad Fortune2, Claude F Burgoyne1.   

Abstract

PURPOSE: To characterize age-related differences in the magnitude of spectral-domain optical coherence tomography (SD-OCT) structural change in early experimental glaucoma (EG).
METHODS: Both eyes from four young (1.4-2.6 years) and four old (18.6-21.9 years) rhesus monkeys were imaged at least three times at baseline, and then every 2 weeks after laser-induced, chronic, unilateral IOP elevation until the onset of EG (confocal scanning laser tomographic surface change confirmed twice). Two to 20 weeks after EG onset, animals were euthanized and optic nerve axon counts for all eyes were performed. Masked operators delineated retinal and ONH landmarks in 40 radial B-scans from each eye and imaging session to quantify change from baseline in five SD-OCT neural and connective tissue parameters. The effects of EG, age, and EG × age interactions on the magnitude, rate (magnitude per postlaser time), and IOP responsiveness (magnitude per cumulative IOP insult) of postlaser parameter change were individually assessed using general estimating equation models.
RESULTS: Presac SD-OCT RNFLT and minimum rim width change and postmortem axon loss was not significantly different in old compared with young EG eyes. The rate of change and IOP responsiveness of the parameters anterior lamina cribrosa surface depth relative to Bruch's membrane opening (BMO) and BMO depth relative to peripheral Bruch's membrane were significantly lower (P < 0.05) in the old compared with the young EG eyes.
CONCLUSIONS: At similar postlaser times, levels of cumulative IOP insult and axonal damage, SD-OCT-detected ONH connective tissue structural change is greater in young compared with old monkey EG eyes. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  BMO minimum rim width; glaucoma; lamina cribrosa; optic nerve head; optical coherence tomography

Mesh:

Year:  2014        PMID: 25190652      PMCID: PMC4197684          DOI: 10.1167/iovs.14-14156

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  49 in total

1.  Optic disc surface compliance testing using confocal scanning laser tomography in the normal monkey eye.

Authors:  A G Heickell; A J Bellezza; H W Thompson; C F Burgoyne
Journal:  J Glaucoma       Date:  2001-10       Impact factor: 2.503

2.  Effect of acute intraocular pressure elevation on the monkey optic nerve head as detected by spectral domain optical coherence tomography.

Authors:  Nicholas G Strouthidis; Brad Fortune; Hongli Yang; Ian A Sigal; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

3.  24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.

Authors:  J Crawford Downs; Claude F Burgoyne; William P Seigfreid; Juan F Reynaud; Nicholas G Strouthidis; Verney Sallee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-21       Impact factor: 4.799

4.  Biomechanics of the human posterior sclera: age- and glaucoma-related changes measured using inflation testing.

Authors:  Baptiste Coudrillier; Jing Tian; Stephen Alexander; Kristin M Myers; Harry A Quigley; Thao D Nguyen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-02       Impact factor: 4.799

5.  Nonglaucomatous excavation of the optic disc.

Authors:  J D Trobe; J S Glaser; J Cassady; J Herschler; D R Anderson
Journal:  Arch Ophthalmol       Date:  1980-06

6.  Cupping of the optic disc in ischemic optic neuropathy.

Authors:  H Quigley; D R Anderson
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 Sep-Oct

7.  Spectral-domain optical coherence tomography enhanced depth imaging of the normal and glaucomatous nonhuman primate optic nerve head.

Authors:  Hongli Yang; Jingjing Qi; Christy Hardin; Stuart K Gardiner; Nicholas G Strouthidis; Brad Fortune; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

8.  Automated quantification of optic nerve axons in primate glaucomatous and normal eyes--method and comparison to semi-automated manual quantification.

Authors:  Juan Reynaud; Grant Cull; Lin Wang; Brad Fortune; Stuart Gardiner; Claude F Burgoyne; George A Cioffi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-01       Impact factor: 4.799

9.  Clock-hour laminar displacement and age in primary open-angle glaucoma and normal tension glaucoma.

Authors:  Chang Rae Rho; Hae-Young Lopilly Park; Na Young Lee; Chan Kee Park
Journal:  Clin Exp Ophthalmol       Date:  2011-10-20       Impact factor: 4.207

10.  Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma.

Authors:  Stuart K Gardiner; Brad Fortune; Lin Wang; J Crawford Downs; Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2012-08-08       Impact factor: 3.467

View more
  15 in total

Review 1.  The morphological difference between glaucoma and other optic neuropathies.

Authors:  Claude Burgoyne
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

Review 2.  In vivo imaging methods to assess glaucomatous optic neuropathy.

Authors:  Brad Fortune
Journal:  Exp Eye Res       Date:  2015-06-03       Impact factor: 3.467

3.  The non-human primate experimental glaucoma model.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-06-09       Impact factor: 3.467

Review 4.  Lamina cribrosa in glaucoma.

Authors:  J Crawford Downs; Christopher A Girkin
Journal:  Curr Opin Ophthalmol       Date:  2017-03       Impact factor: 3.761

5.  Relating Retinal Ganglion Cell Function and Retinal Nerve Fiber Layer (RNFL) Retardance to Progressive Loss of RNFL Thickness and Optic Nerve Axons in Experimental Glaucoma.

Authors:  Brad Fortune; Grant Cull; Juan Reynaud; Lin Wang; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

6.  Enhanced Diagnostic Capability for Glaucoma of 3-Dimensional Versus 2-Dimensional Neuroretinal Rim Parameters Using Spectral Domain Optical Coherence Tomography.

Authors:  Kenneth C Fan; Edem Tsikata; Ziad Khoueir; Huseyin Simavli; Rong Guo; Regina A de Luna; Sumir Pandit; Christian J Que; Johannes F de Boer; Teresa C Chen
Journal:  J Glaucoma       Date:  2017-05       Impact factor: 2.503

Review 7.  The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.

Authors:  Hongli Yang; Juan Reynaud; Howard Lockwood; Galen Williams; Christy Hardin; Luke Reyes; Cheri Stowell; Stuart K Gardiner; Claude F Burgoyne
Journal:  Prog Retin Eye Res       Date:  2017-03-12       Impact factor: 21.198

8.  The Connective Tissue Components of Optic Nerve Head Cupping in Monkey Experimental Glaucoma Part 1: Global Change.

Authors:  Hongli Yang; Ruojin Ren; Howard Lockwood; Galen Williams; Vincent Libertiaux; Crawford Downs; Stuart K Gardiner; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

9.  Posterior rat eye during acute intraocular pressure elevation studied using polarization sensitive optical coherence tomography.

Authors:  Stanislava Fialová; Marco Augustin; Corinna Fischak; Leopold Schmetterer; Stephan Handschuh; Martin Glösmann; Michael Pircher; Christoph K Hitzenberger; Bernhard Baumann
Journal:  Biomed Opt Express       Date:  2016-12-16       Impact factor: 3.732

10.  Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.

Authors:  Leandro B C Teixeira; James N Ver Hoeve; Joshua A Mayer; Richard R Dubielzig; Chelsey M Smith; Abigail B Radcliff; Ian D Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.